Stay updated on Optimal Tenecteplase Dose in Stroke Clinical Trial
Sign up to get notified when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.

Latest updates to the Optimal Tenecteplase Dose in Stroke Clinical Trial page
- Check3 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.5.0 replaces the previous v3.4.3.SummaryDifference0.0%

- Check39 days agoChange Detected- Revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision: v3.4.2 is now shown. The previous Revision: v3.4.1 note and a general government funding-status notice were removed.SummaryDifference0.3%

- Check75 days agoChange DetectedA general funding-status notice was added. The page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check82 days agoChange DetectedNew UI/text changes include adding a Show glossary option and updating the footer to display 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The prior footer entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

Stay in the know with updates to Optimal Tenecteplase Dose in Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.